In the Eye of Controversy: A Deeper Look Into the Impact of Glucagon-like Peptide-1 Receptor Agonists on Diabetic Retinopathy and Nonarteritic Anterior Ischemic Optic Neuropathy.

Saved in:
Bibliographic Details
Title: In the Eye of Controversy: A Deeper Look Into the Impact of Glucagon-like Peptide-1 Receptor Agonists on Diabetic Retinopathy and Nonarteritic Anterior Ischemic Optic Neuropathy.
Authors: Nadeem N; Department of Internal Medicine, Rashid Hospital, Dubai Health, Dubai, United Arab Emirates. Electronic address: nadianadeem24@gmail.com., Al Issa RM; Department of Internal Medicine, Rashid Hospital, Dubai Health, Dubai, United Arab Emirates., Shah A; Department of Endocrinology, Dubai Hospital, Dubai Health, Dubai, United Arab Emirates., Wardeh R; Department of Endocrinology, Dubai Hospital, Dubai Health, Dubai, United Arab Emirates., Rashid F; Department of Endocrinology, Dubai Hospital, Dubai Health, Dubai, United Arab Emirates., Abdelgadir EI; Department of Endocrinology, Dubai Hospital, Dubai Health, Dubai, United Arab Emirates., Bashier A; Department of Endocrinology, Dubai Hospital, Dubai Health, Dubai, United Arab Emirates.
Source: Canadian journal of diabetes [Can J Diabetes] 2025 Oct; Vol. 49 (7), pp. 401-410. Date of Electronic Publication: 2025 Jul 23.
Publication Type: Journal Article; Review
Journal Info: Publisher: Canadian Diabetes Association Country of Publication: Canada NLM ID: 101148810 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3840 (Electronic) Linking ISSN: 14992671 NLM ISO Abbreviation: Can J Diabetes Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2352-3840
DOI:10.1016/j.jcjd.2025.07.002